Kyruus, a Boston-based healthcare tech company, has raised an $11 million Series B from Lux Capital, Fidelity Biosciences, Venrock, and Highland Capital Partners. The funding will be used to bolster the company’s sales efforts.
“On January 25, 1995, at 9:28 A.M. Moscow time, an aide handed a briefcase to Boris Yeltsin… A small light near the handle was on, and inside was a screen displaying information indicating that a missile had been launched four minutes earlier from somewhere in the vicinity of the Norwegian Sea, and that it appeared to be headed toward Moscow. Below the screen was a row of buttons. This was the Russian “nuclear football…” — The New Yorker